LD 710 Maine House · 132nd Legislature (2025-2026)

An Act To Expand Access And Reduce Barriers To Access To Naloxone Hydrochloride And Other Opioid Overdose-Reversing Medications

LD 710 expands access to naloxone and similar opioid overdose-reversing medications in Maine. It removes training requirements for community overdose prevention programs and recovery residences that distribute these medications, and allows municipalities to place naloxone in public locations like wall-mounted boxes or vending machines in places such as libraries or parks. The bill also provides immunity from legal liability for anyone who administers these medications in good faith during an opioid overdose emergency. These changes apply to both naloxone hydrochloride and other approved opioid overdose-reversing medications.
Bill status signed all 5 stages cleared
Introduction
Feb 2025
Committee Review
May 2025
House Passage
May 2025
Senate Passage
May 2025
Signed into Law
May 2025
Introduced Feb 20, 2025 Signed May 29, 2025
Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
19
Key actions
5
Committee
3
May 29, 2025
Signed into law
Signed by Governor
executive
May 27, 2025
Upper · Passed
PASSED TO BE ENACTED, in concurrence.
upper
May 27, 2025
Lower · Passed
PASSED TO BE ENACTED.
lower
May 22, 2025
Upper · Passed
Committee Amendment "A" (H-207) READ and ADOPTED, in concurrence.
upper
May 19, 2025
Legislature · Passed
Reported Out - OTP-AM
legislature
Feb 20, 2025
Committee
The Bill was REFERRED to the Committee on HEALTH AND HUMAN SERVICES pursuant to Joint Rule 308.2 and ordered printed pursuant to Joint Rule 401.
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Sam Zager
Sam Zager
DDemocratic
ME
116